2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

Rebecca B. Perkins; Richard S. Guido; Philip E. Castle; David Chelmow; Mark H. Einstein; Francisco Garcia; Warner K. Huh; Jane J. Kim; Anna-Barbara Moscicki; Ritu Nayar; Mona Saraiya; George F. Sawaya; Nicolas Wentzensen; Mark Schiffman; 2019 ASCCP Risk Based Management; Amy Wiser

doi:10.1097/LGT.0000000000000788

Back

2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

Journal article

Open access

Peer reviewed

2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

Rebecca B. Perkins, Richard S. Guido, Philip E. Castle, David Chelmow, Mark H. Einstein, Francisco Garcia, Warner K. Huh, Jane J. Kim, Anna-Barbara Moscicki, Ritu Nayar, …

Journal of lower genital tract disease, Vol.28(1), pp.3-6

01/01/2024

DOI: 10.1097/LGT.0000000000000788

PMID: 38117563

Files and links (1)

url

https://doi.org/10.1097/LGT.0000000000000788View

Published (Version of record) Open Access

Abstract

This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.

Life Sciences & Biomedicine

Obstetrics & Gynecology

Science & Technology

Details

Title: Subtitle: 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023
Creators: Rebecca B. Perkins - Boston University
Richard S. Guido - University of Pittsburgh
Philip E. Castle - National Cancer Institute
David Chelmow - Virginia Commonwealth University
Mark H. Einstein - Rutgers, The State University of New Jersey
Francisco Garcia - Pima County Health Department
Warner K. Huh - University of Alabama School of Medicine
Jane J. Kim - Harvard University
Anna-Barbara Moscicki - University of California, Los Angeles
Ritu Nayar - Northwestern University
Mona Saraiya - Centers for Disease Control and Prevention
George F. Sawaya - University of California, San Francisco
Nicolas Wentzensen - National Cancer Institute
Mark Schiffman - National Cancer Institute
2019 ASCCP Risk Based Management
Amy Wiser (Contributor) - Family and Community Medicine
Resource Type: Journal article
Publication Details: Journal of lower genital tract disease, Vol.28(1), pp.3-6
DOI: 10.1097/LGT.0000000000000788
PMID: 38117563
NLM abbreviation: J Low Genit Tract Dis
ISSN: 1089-2591
eISSN: 1526-0976
Publisher: Lippincott Williams & Wilkins
Number of pages: 4
Language: English
Date published: 01/01/2024
Academic Unit: Family and Community Medicine
Record Identifier: 9985134037502771

Metrics

1 Record Views